Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Aisner

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2019
A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and PoziotinibGina M Castellano, Joseph Aisner, Stephen K Burley, et al.
Journal of Cancer Research and Therapeutics|July 28, 2016
Modern induction chemotherapy before chemoradiation for bulky locally-advanced nonsmall cell lung cancer improves survivalInaya Ahmed, Adam Ferro, Rekha Baby, et al.
Shanghai Chest|February 1, 2021
Combining radiation therapy and immunotherapy for lung cancers: a narrative reviewChirag Modi, Lyudmyla Berim, Lauren Isserow, et al.
American Journal of Clinical Oncology|June 21, 2016
Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung CancerMatthew P Deek, Sinae Kim, Inaya Ahmed, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2019
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerSanjay Goel, Umang Swami, Kirushna Kumar, et al.
Advances in Radiation Oncology|July 31, 2019
Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single InstitutionNikhil Yegya-Raman, Joseph Aisner, Sinae Kim, et al.
Journal of Thoracic Disease|October 18, 2016
Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapyMatthew P Deek, Sinae Kim, Ning Yue, et al.
Clinical Lung Cancer|May 13, 2018
Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall SurvivalMatthew P Deek, Sinae Kim, Robert Beck, et al.
Practical Radiation Oncology|August 26, 2018
Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation TherapyNikhil Yegya-Raman, Meral Reyhan, Sinae Kim, et al.
Journal of Thoracic Disease|April 30, 2015
Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiationInaya Ahmed, Adam Ferro, Alan Cohler, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2019
A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and PoziotinibGina M Castellano, Joseph Aisner, Stephen K Burley, et al.
Journal of Cancer Research and Therapeutics|July 28, 2016
Modern induction chemotherapy before chemoradiation for bulky locally-advanced nonsmall cell lung cancer improves survivalInaya Ahmed, Adam Ferro, Rekha Baby, et al.
Shanghai Chest|February 1, 2021
Combining radiation therapy and immunotherapy for lung cancers: a narrative reviewChirag Modi, Lyudmyla Berim, Lauren Isserow, et al.
American Journal of Clinical Oncology|June 21, 2016
Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung CancerMatthew P Deek, Sinae Kim, Inaya Ahmed, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2019
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerSanjay Goel, Umang Swami, Kirushna Kumar, et al.
Advances in Radiation Oncology|July 31, 2019
Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single InstitutionNikhil Yegya-Raman, Joseph Aisner, Sinae Kim, et al.
Journal of Thoracic Disease|October 18, 2016
Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapyMatthew P Deek, Sinae Kim, Ning Yue, et al.
Clinical Lung Cancer|May 13, 2018
Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall SurvivalMatthew P Deek, Sinae Kim, Robert Beck, et al.
Practical Radiation Oncology|August 26, 2018
Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation TherapyNikhil Yegya-Raman, Meral Reyhan, Sinae Kim, et al.
Journal of Thoracic Disease|April 30, 2015
Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiationInaya Ahmed, Adam Ferro, Alan Cohler, et al.
Pageof 7